- Home
- GME vs SCLXW Comparison
GME vs SCLXW Comparison
Compare GME & SCLXW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GME
- SCLXW
- Stock Information
- Founded
- GME 1996
- SCLXW N/A
- Country
- GME United States
- SCLXW United States
- Employees
- GME N/A
- SCLXW 111
- Industry
- GME Electronics Distribution
- SCLXW Biotechnology: Pharmaceutical Preparations
- Sector
- GME Consumer Discretionary
- SCLXW Health Care
- Exchange
- GME Nasdaq
- SCLXW Nasdaq
- Market Cap
- GME 10.5B
- SCLXW N/A
- IPO Year
- GME 2002
- SCLXW N/A
- Fundamental
- Price
- GME $23.35
- SCLXW $0.10
- Analyst Decision
- GME Sell
- SCLXW
- Analyst Count
- GME 1
- SCLXW 0
- Target Price
- GME $13.50
- SCLXW N/A
- AVG Volume (30 Days)
- GME 23.0M
- SCLXW 4.0K
- Earning Date
- GME 09-09-2025
- SCLXW 03-07-2025
- Dividend Yield
- GME N/A
- SCLXW N/A
- EPS Growth
- GME 494.62
- SCLXW N/A
- EPS
- GME 0.47
- SCLXW N/A
- Revenue
- GME $3,673,600,000.00
- SCLXW $55,152,000.00
- Revenue This Year
- GME N/A
- SCLXW N/A
- Revenue Next Year
- GME N/A
- SCLXW N/A
- P/E Ratio
- GME $49.49
- SCLXW N/A
- Revenue Growth
- GME N/A
- SCLXW 22.02
- 52 Week Low
- GME $18.73
- SCLXW $0.18
- 52 Week High
- GME $35.81
- SCLXW $0.18
- Technical
- Relative Strength Index (RSI)
- GME 41.88
- SCLXW N/A
- Support Level
- GME $22.53
- SCLXW N/A
- Resistance Level
- GME $23.60
- SCLXW N/A
- Average True Range (ATR)
- GME 0.71
- SCLXW 0.00
- MACD
- GME 0.11
- SCLXW 0.00
- Stochastic Oscillator
- GME 43.95
- SCLXW 0.00
About GME GameStop Corporation
GameStop Corp is a U.S. multichannel video game, consumer electronics, and services retailer. The company operates across Europe, Canada, Australia, and the United States. The company sells new and second-hand video game hardware, physical and digital video game software, and video game accessories, mainly through GameStop, EB Games, and Micromania stores and international e-commerce sites. The majority of sales are from the United States. The company categorizes its products in three categories: Hardware and accessories, Software, and Collectibles. The company generates the majority of its revenue from the sale of Hardware and accessories products.
About SCLXW Scilex Holding Company
Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.